Bicycle Therapeutics Plc (BCYC)
3.38
-0.18
(-5.06%)
USD |
NASDAQ |
Oct 02, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Max Drawdown (5Y) : 94.11% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.11% |
| August 31, 2026 | 93.69% |
| July 31, 2026 | 93.69% |
| June 30, 2026 | 93.52% |
| May 31, 2026 | 92.95% |
| April 30, 2026 | 92.95% |
| March 31, 2026 | 92.95% |
| February 28, 2026 | 91.45% |
| January 31, 2026 | 89.91% |
| December 31, 2025 | 89.91% |
| November 30, 2025 | 89.91% |
| October 31, 2025 | 89.56% |
| September 30, 2025 | 89.56% |
| August 31, 2025 | 89.56% |
| July 31, 2025 | 89.56% |
| June 30, 2025 | 89.56% |
| May 31, 2025 | 89.56% |
| April 30, 2025 | 89.56% |
| March 31, 2025 | 86.11% |
| February 28, 2025 | 82.06% |
| January 31, 2025 | 79.11% |
| December 31, 2024 | 78.82% |
| November 30, 2024 | 78.82% |
| October 31, 2024 | 78.82% |
| September 30, 2024 | 78.82% |
| Date | Value |
|---|---|
| August 31, 2024 | 78.82% |
| July 31, 2024 | 78.82% |
| June 30, 2024 | 78.82% |
| May 31, 2024 | 78.82% |
| April 30, 2024 | 78.82% |
| March 31, 2024 | 78.82% |
| February 29, 2024 | 78.82% |
| January 31, 2024 | 78.82% |
| December 31, 2023 | 78.82% |
| November 30, 2023 | 78.82% |
| October 31, 2023 | 78.82% |
| September 30, 2023 | 78.82% |
| August 31, 2023 | 78.82% |
| July 31, 2023 | 78.82% |
| June 30, 2023 | 78.82% |
| May 31, 2023 | 78.82% |
| April 30, 2023 | 78.82% |
| March 31, 2023 | 78.82% |
| February 28, 2023 | 78.82% |
| January 31, 2023 | 78.82% |
| December 31, 2022 | 78.82% |
| November 30, 2022 | 78.82% |
| October 31, 2022 | 78.82% |
| September 30, 2022 | 78.82% |
| August 31, 2022 | 78.82% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Autolus Therapeutics Plc | 96.58% |
| Akari Therapeutics Plc | 99.83% |
| Cellectis SA | 97.08% |
| DBV Technologies SA | 98.19% |
| Oxford Biomedica Plc | 90.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -59.04 |
| Beta (5Y) | 1.682 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.66% |
| Historical Sharpe Ratio (5Y) | -0.7076 |
| Historical Sortino (5Y) | -1.238 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.78% |